• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT6表达降低促进肿瘤细胞生长,这与卵巢癌的不良预后密切相关。

Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer.

作者信息

Zhang G, Liu Z, Qin S, Li K

出版信息

Eur J Gynaecol Oncol. 2015;36(6):629-32.

PMID:26775341
Abstract

INTRODUCTION

Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not con-trolled, it can result in death. Sirtunins belong to a protein family and it is present in all organisms. SIRT6 is downregulated in tumor and acts as tumor suppressor. These sirtunin proteins are linked to repair DNA and metabolism.

MATERIAL AND METHODS

To measure the role of SIRT6 in tumor cell, 20 mice were used and European Collection of Cell Cultures (ECACC) cell lines were used for the analysis. A histopathological technique showed the level of tumor cells.

RESULTS

A recent study provided exceptional insight into the mechanism of SIRT6-related chromatin regulation. According to the histopathology of cancer, SIRT1 localizes to the promoters of several aberrantly silenced tumor suppressor genes whose DNA is hypermethylated. SIRT1 has a role associated with the epigenetic hallmarks of cancer.

CONCLUSION

The link between SIRT6 and cancer provide new insight into the therapeutic potential of small molecule activators or specific targets of SIRT6 for the prevention and treatment of cancer. Further investigation into the specific mechanism of SIRT6 is required to realize this potential.

摘要

引言

癌症是一组以异常细胞不受控制地生长和扩散为特征的疾病。如果这种扩散得不到控制,可能会导致死亡。沉默调节蛋白属于一个蛋白质家族,存在于所有生物体中。SIRT6在肿瘤中表达下调,并起到肿瘤抑制作用。这些沉默调节蛋白与DNA修复和代谢有关。

材料与方法

为了测定SIRT6在肿瘤细胞中的作用,使用了20只小鼠,并使用欧洲细胞培养物保藏中心(ECACC)的细胞系进行分析。一种组织病理学技术显示了肿瘤细胞的水平。

结果

最近的一项研究对SIRT6相关的染色质调控机制提供了独特的见解。根据癌症的组织病理学,SIRT1定位于几个DNA发生高甲基化的异常沉默的肿瘤抑制基因的启动子区域。SIRT1具有与癌症的表观遗传特征相关的作用。

结论

SIRT6与癌症之间的联系为小分子激活剂或SIRT6的特定靶点在癌症预防和治疗方面的治疗潜力提供了新的见解。需要进一步研究SIRT6的具体机制以实现这一潜力。

相似文献

1
Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer.SIRT6表达降低促进肿瘤细胞生长,这与卵巢癌的不良预后密切相关。
Eur J Gynaecol Oncol. 2015;36(6):629-32.
2
The histone deacetylase SIRT6 inhibits ovarian cancer cell proliferation via down-regulation of Notch 3 expression.组蛋白去乙酰化酶SIRT6通过下调Notch 3表达抑制卵巢癌细胞增殖。
Eur Rev Med Pharmacol Sci. 2015;19(5):818-24.
3
SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC.SIRT6缺失通过促进肝癌中DNA损伤诱导的细胞衰老来抑制肿瘤生长。
PLoS One. 2016 Nov 8;11(11):e0165835. doi: 10.1371/journal.pone.0165835. eCollection 2016.
4
SIRT6 promotes mitochondrial fission and subsequent cellular invasion in ovarian cancer.SIRT6 促进卵巢癌细胞中线粒体分裂和随后的细胞侵袭。
FEBS Open Bio. 2022 Sep;12(9):1657-1676. doi: 10.1002/2211-5463.13452. Epub 2022 Jun 24.
5
SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.SIRT6促进COX - 2表达,并在皮肤癌中作为一种癌基因发挥作用。
Cancer Res. 2014 Oct 15;74(20):5925-33. doi: 10.1158/0008-5472.CAN-14-1308.
6
SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.SIRT6 通过抑制 JAK2/STAT3 通路抑制胃癌的生长。
Oncol Rep. 2017 Aug;38(2):1059-1066. doi: 10.3892/or.2017.5753. Epub 2017 Jun 27.
7
Effects of vinclozolin exposure on the expression and activity of SIRT1 and SIRT6 in the porcine ovary.氯卓斯汀暴露对猪卵巢中 SIRT1 和 SIRT6 的表达和活性的影响。
J Physiol Pharmacol. 2019 Feb;70(1). doi: 10.26402/jpp.2019.1.15. Epub 2019 Jun 3.
8
The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.RUNX2转录因子负向调节SIRT6表达以改变乳腺癌细胞中的葡萄糖代谢。
J Cell Biochem. 2015 Oct;116(10):2210-26. doi: 10.1002/jcb.25171.
9
The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.组蛋白去乙酰化酶 SIRT6 抑制脑胶质瘤中 RNA 结合蛋白 PCBP2 的表达。
Biochem Biophys Res Commun. 2014 Mar 28;446(1):364-9. doi: 10.1016/j.bbrc.2014.02.116. Epub 2014 Mar 4.
10
Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.缺乏哺乳动物SIRT6时的基因组不稳定和衰老样表型。
Cell. 2006 Jan 27;124(2):315-29. doi: 10.1016/j.cell.2005.11.044.

引用本文的文献

1
Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development.线粒体去乙酰化酶SIRT5在琥珀酰化修饰和癌症发展中的新作用。
Front Immunol. 2025 Jan 29;16:1531246. doi: 10.3389/fimmu.2025.1531246. eCollection 2025.
2
Sirtuin Modulators in Cellular and Animal Models of Human Diseases.人类疾病细胞和动物模型中的Sirtuin调节剂
Front Pharmacol. 2021 Sep 28;12:735044. doi: 10.3389/fphar.2021.735044. eCollection 2021.
3
Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer.
磁性脂质体紫杉醇纳米粒作为治疗卵巢癌潜在载体的评估
Adv Pharm Bull. 2021 Feb;11(2):267-273. doi: 10.34172/apb.2021.039. Epub 2020 Aug 5.
4
Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review.尿路上皮细胞癌的治疗策略和代谢途径调控:全面综述。
Int J Mol Sci. 2020 Nov 26;21(23):8993. doi: 10.3390/ijms21238993.
5
MicroRNA-572/hMOF/Sirt6 regulates the progression of ovarian cancer.miRNA-572/hMOF/Sirt6 调控卵巢癌的进展。
Cell Cycle. 2020 Oct;19(19):2509-2518. doi: 10.1080/15384101.2020.1809258. Epub 2020 Aug 23.
6
Gene expression and prognosis of sirtuin family members in ovarian cancer.卵巢癌中沉默调节蛋白家族成员的基因表达与预后
Medicine (Baltimore). 2020 Jun 12;99(24):e20685. doi: 10.1097/MD.0000000000020685.
7
Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D in colorectal cancer.小分子激活 SIRT6 可发挥治疗作用,并协同促进维生素 D 在结直肠癌中的抗肿瘤活性。
Theranostics. 2020 Apr 27;10(13):5845-5864. doi: 10.7150/thno.44043. eCollection 2020.
8
MiR-128 inhibits the osteogenic differentiation in osteoporosis by down-regulating SIRT6 expression.miR-128 通过下调 SIRT6 表达抑制骨质疏松症中的成骨分化。
Biosci Rep. 2019 Sep 24;39(9). doi: 10.1042/BSR20191405. Print 2019 Sep 30.
9
Epigenetic Dysregulation at the Crossroad of Women's Cancer.女性癌症交叉路口的表观遗传失调
Cancers (Basel). 2019 Aug 16;11(8):1193. doi: 10.3390/cancers11081193.
10
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer.开发和验证与 SIRT3 相关的列线图,以预测浆液性卵巢癌患者的总生存率。
J Ovarian Res. 2019 May 21;12(1):47. doi: 10.1186/s13048-019-0524-2.